4694.T
Latest Trade
3,260.00JPYChange
35.00(+1.09%)Volume
10,000Today's Range
-
3,260.0052 Week Range
-
3,500.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 3,225.00 |
|---|---|
Open | 3,225.00 |
Volume | 10,000 |
3M AVG Volume | 1.21 |
Today's High | 3,260.00 |
Today's Low | 3,225.00 |
52 Week High | 3,500.00 |
52 Week Low | 2,653.00 |
Shares Out (MIL) | 42.61 |
Market Cap (MIL) | 141,507.30 |
Forward P/E | 19.77 |
Dividend (Yield %) | 1.21 |
BML to acquire 100 pct stake in The Tohkai Cytopathology Institute
BML says shareholding structure change
BML announces change of corporate auditor
BML, INC. is mainly engaged in the clinical testing as well as related business. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.
Industry
Healthcare Facilities
Executive Leadership
Kensuke Kondo
President, Chairman of Subsidiaries, Representative Director
Masaaki Hirose
Senior Managing Executive Officer, Chief Senior Director of Sales, Director of Sales Administration, Director of Electronic Medical Record Support, Director
Nobuki Arai
Senior Managing Executive Officer, Chief Director of Planning, Director of BML General Research Institute, Manager of Overseas Business Office, Representative Director
Masato Chikira
Managing Executive Officer, Chief Director of System, Director
Masato Nakagawa
Managing Executive Officer, Chief Senior Director of Examination, Chief Director of Satellite Examination, Director
Price To Earnings (TTM) | 19.60 |
|---|---|
Price To Sales (TTM) | 1.18 |
Price To Book (MRQ) | 1.70 |
Price To Cash Flow (TTM) | 11.16 |
Total Debt To Equity (MRQ) | 0.00 |
LT Debt To Equity (MRQ) | 0.00 |
Return on Investment (TTM) | 8.86 |
Return on Equity (TTM) | 6.40 |
* Says it appoints Deloitte Touche Tohmatsu LLC as new corporate auditor to replace Ernst & Young ShinNihon LLC, effective June 29
* Entered into a share sale and purchase agreement with shareholders of Fintech Pte Ltd and a subscription agreement with BML
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.